FGF-23 CKD Progression Risk Assessment

Assess the prognostic significance of elevated FGF-23 levels in CKD for predicting disease progression, cardiovascular events, and all-cause mortality beyond traditional GFR and albuminuria staging.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How to Use

Enter the values for the scenario you are assessing. Assess the prognostic significance of elevated FGF-23 levels in CKD for predicting disease progression, cardiovascular events, and all-cause mortality beyond traditional GFR and albuminuria staging. Use the fgf-23 ckd risk result to inform your calculation.

Frequently Asked Questions